s6y

Mosaic ImmunoEngineering Inc.

Ticker
CPMV
CIK
836564
Industry
Biological Products, (No Diagnostic Substances)
Formerly
PATRIOT SCIENTIFIC CORP

Financials 118

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2026
  3. 10-Q Quarterly Report for period ending Jun 30, 2026
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  6. 10-K Annual Report for period ending Dec 31, 2025
  7. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  8. 10-Q Quarterly Report for period ending Sep 30, 2025
  9. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2025
  10. 10-Q Quarterly Report for period ending Jun 30, 2025

All 118 financials filings

News 123

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 123 news filings

Ownership 151

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 151 ownership filings

Prospectus 35

  1. RW Registration Withdrawal Request
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. S-3/A Registration statement for specified transactions by certain issuers
  5. S-3 Registration statement for specified transactions by certain issuers
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. S-1 General form of registration statement for all companies including face-amount certificate companies

All 35 prospectus filings

Proxies 35

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  3. DEF 14C Definitive information statements
  4. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements
  8. DEF 14A Definitive proxy statements
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEF 14A Definitive proxy statements

All 35 proxies filings

Other 93

  1. EFFECT Notice of Effectiveness
  2. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  3. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  4. UPLOAD Letter (PDF)
  5. CT ORDER Order Granting Confidential Treatment
  6. CT ORDER Order Granting Confidential Treatment
  7. CT ORDER Order Granting Confidential Treatment
  8. CT ORDER Order Granting Confidential Treatment
  9. NO ACT
  10. NO ACT

All 93 other filings